Genomics of Rare Diseases25 - 27 March 2020Wellcome Genome Campus, UK
Deadlines (at 23:59 UTC):
- Early bird deadline 07 January 2020
- Bursary deadline 14 January 2020
- Abstract deadline 28 January 2020
- Registration deadline 25 February 2020
Registration opens soon.
Email for updates.
Exploring how genomic research translates into clinical care and informs our understanding of the biology of rare disease
We are pleased to announce the 14th in our series of meetings on rare diseases, which will present an exciting blend of genomic science and clinical medicine. This conference will explore how cutting-edge genomic research translates into clinical care and informs our understanding of the biology of rare disease.
The programme features the latest findings related to the genomic basis of rare diseases, providing powerful insights into human biology, disease mechanisms and therapeutic approaches. As genomic sequencing becomes more available in the hospital setting, we also examine the opportunities and challenges for clinical practice.
This year’s meeting will focus on large-scale whole genome sequencing studies that impact on our understanding of rare diseases. There will also be the opportunity for bioinformaticians working in this area to showcase the innovative tools that they have developed. We will also include sessions exploring regulatory regions beyond the coding regions of the genome, and explore the new therapeutic approaches to rare diseases.
This conference provides an excellent multi-disciplinary forum for clinicians (consultants and trainees), research and clinical scientists, bioinformaticians and technology developers interested in understanding the impact of recent advances in genomics and technology on the care of patients with rare diseases.
The conference will start at approximately 12.30 on Wednesday, 25 March and close at approximately 14.00 on Friday 27 March 2020.
Topics will include:
- What’s new in rare disease?
- Developmental genetics
- Functional genomics
- Beyond the coding genome
- New therapeutic approaches
- Organisers/ Speakers
Scientific programme committee
Baylor College of Medicine, USA
Wellcome Sanger Institute, UK
University Medical Centre Nijmegen, The Netherlands
Imperial College London, UK
Institute for Molecular Medicine, Finland
A list of confirmed speakers will be available soon
Scientific Conferences Team
Treasa Creavin, Scientific Programme Manager
Zoey Willard, Conference & Events Organiser
- Registration/ Accommodation
Early bird discount
(until 7 January)
(after 7 January)
Student No accommodation Student On-site twin accommodation Student On-site single accommodation Academic No accommodation Academic On-site twin accommodation Academic On-site single accommodation Commercial No accommodation Commercial On-site twin accommodation Commercial On-site single accommodation
The registration fee includes entrance to the lectures and poster sessions, an abstract book, meals (lunch and dinner) and refreshments during the conference. Breakfast will be provided for delegates who have booked on-site accommodation.
Accommodation is provided for the nights of 25 and 26 March 2020. Please note: there is limited onsite accommodation and this will be allocated on a first-come, first-served basis. Therefore, early registration is recommended.
If you wish to book onsite accommodation either side of the conference dates, please contact the Conference Centre directly.
Contact the conference organiser if you require a letter to support a travel visa application. Please note: letters will only be provided to confirmed registrants.
Non-European Economic Area or Swiss nationals may be required to have a visa to enter the UK.
Early application is strongly advised, as this process can take 6-8 weeks or longer.
Please visit the following websites for further information:
Accommodation services phishing scam – please be vigilant. More information.
We welcome abstracts from all areas relevant to the main themes of the meeting, for both oral and poster presentations. Several oral presentations will be chosen from the abstracts submitted.
Abstracts will only be considered from registered delegates. Please use our online abstract submission system and follow the instructions given to ensure your abstract is submitted correctly. All abstracts must be submitted by the deadline. If you are intending to submit more than one abstract, please contact the conference organiser prior to registration.
The scientific programme committee will assess your abstract after the deadline has passed and you will be notified whether you have been selected for an oral or poster presentation.
Poster boards onsite will accommodate 118 cm high by 84 cm wide (A0- portrait) of printed material. Accepted abstracts will appear in the conference programme book and poster boards will be allocated at the conference.
Abstract deadline: 28 January 2020
A limited number of registration bursaries are available for PhD students to attend this conference (up to 50% of the standard registration fee) from Wellcome Genome Campus Scientific Conferences.
To apply, please contact the conference organiser. You will be sent a unique registration link which will hold your place, without taking payment, until you have been notified of the outcome of your application.
The following documents will need to be provided as part of the bursary application:
- Abstract (to be submitted via the portal during the registration process)
- A justification letter (explain how you will benefit from attending the conference)
- A supporting letter from supervisor stating financial need
If you have already registered for the conference you are still welcome to apply for a bursary, please contact the conference organiser.
Bursary deadline: 14 January 2020.
Additional funding opportunities
Visit our support page for additional financial support currently available.
If you are interested in supporting this meeting, please contact the conference organiser.
- Keynote lecture video from 2019 meeting
Professor Nancy Cox – Exploring the ‘between’ spaces: the continuum from Mendelian to common disease, and the continuum from polygenic to multifactorial disease’